busulfan has been researched along with Hypergonadotropic Hypogonadism in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The most common primary cancer was acute lymphoblastic leukemia (22 patients, 31." | 1.56 | Factors predicting endocrine late effects in childhood cancer survivors from a Japanese hospital. ( Kazukawa, I; Kihara, M; Minagawa, M; Mori, K; Shimazaki, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimazaki, S | 1 |
| Kazukawa, I | 1 |
| Mori, K | 1 |
| Kihara, M | 1 |
| Minagawa, M | 1 |
| Balashov, DN | 1 |
| Papusha, LI | 1 |
| Nazarenko, TA | 1 |
| Trakhtman, PE | 1 |
| Revishvili, NA | 1 |
| Maschan, AA | 1 |
| Persiantseva, MI | 1 |
| Andriutsa, AV | 1 |
| Skorobogatova, EV | 1 |
| Skvortsova, YV | 1 |
| Rumiantsev, AG | 1 |
2 other studies available for busulfan and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
Factors predicting endocrine late effects in childhood cancer survivors from a Japanese hospital.
Topics: Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Busulfan; Cancer Survivors; Child; Chroni | 2020 |
Recovery of ovarian function and pregnancy in a patient with AML after myeloablative busulphan-based conditioning regimen.
Topics: Adolescent; Antineoplastic Agents; Busulfan; Child; Combined Modality Therapy; Female; Hematopoietic | 2011 |